Form 4 for RMD ResMed|
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-22 · accession 0001127602-24-027960 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-25 | 2024-11-22 | RMD | Leong Justin | Chief Product Off | S - Sale | $243.09 | -6,160 | 21.7K | -22% | -$1.50M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ReMed Common Stock | 2024-11-22 | S | D | 6,160 | $243.09 | 21,718 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $243.00 - $243.315. The price reported above reflects the weighted average sale price. |